RITE AID CORP (RAD) Stock Price & Overview
NYSE:RAD • US7677548726
Current stock price
The current stock price of RAD is 0.6483 USD. Today RAD is down by -16.81%. In the past month the price decreased by -2.92%. In the past year, price decreased by -83.2%.
RAD Key Statistics
- Market Cap
- 36.759M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.74
- Dividend Yield
- N/A
RAD Stock Performance
RAD Stock Chart
RAD Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to RAD. When comparing the yearly performance of all stocks, RAD is a bad performer in the overall market: 96.77% of all stocks are doing better.
RAD Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to RAD. RAD has a bad profitability rating. Also its financial health evaluation is rather negative.
RAD Earnings
RAD Forecast & Estimates
10 analysts have analysed RAD and the average price target is 1.02 USD. This implies a price increase of 57.33% is expected in the next year compared to the current price of 0.6483.
For the next year, analysts expect an EPS growth of -86.91% and a revenue growth -3.31% for RAD
RAD Groups
Sector & Classification
RAD Financial Highlights
Over the last trailing twelve months RAD reported a non-GAAP Earnings per Share(EPS) of -2.74. The EPS decreased by -10.04% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -12.37% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
RAD Ownership
RAD Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SRXH | SRX HEALTH SOLUTIONS INC | N/A | 42.92M | ||
| MGRX | MANGOCEUTICALS INC | N/A | 8.653M |
Related stock screener links
View all stocks in the Drug Retail Industry | View all stocks in the Consumer Staples Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About RAD
Company Profile
Rite Aid Corp. engages in the ownership and management of retail drug stores. The company is headquartered in Philadelphia, Pennsylvania and currently employs 47,000 full-time employees. The firm is engaged in providing its services to customers and communities through various programs. The company operates through two segments: the Retail Pharmacy segment and the Pharmacy Services segment. The Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as front-end products, including health and beauty aids, personal care products and seasonal merchandise. The Pharmacy Services Segment, which consists of Elixir, its pharmacy benefit management (PBM) business, provides a suite of PBM offerings including technology solutions, mail delivery services, specialty pharmacy, network, and rebate administration, claims adjudication, and pharmacy discount programs. Elixir also provides prescription discount programs and Medicare Part D insurance offerings for individuals and groups. The company operates over 2,300 retail pharmacy locations across 17 states.
Company Info
IPO: 1981-05-22
RITE AID CORP
1200 Intrepid Avenue, 2nd Floor
PHILADELPHIA PENNSYLVANIA 17011 US
CEO: Heyward Donigan
Employees: 47000
Phone: 17177612633.0
RITE AID CORP / RAD FAQ
What does RITE AID CORP do?
Rite Aid Corp. engages in the ownership and management of retail drug stores. The company is headquartered in Philadelphia, Pennsylvania and currently employs 47,000 full-time employees. The firm is engaged in providing its services to customers and communities through various programs. The company operates through two segments: the Retail Pharmacy segment and the Pharmacy Services segment. The Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as front-end products, including health and beauty aids, personal care products and seasonal merchandise. The Pharmacy Services Segment, which consists of Elixir, its pharmacy benefit management (PBM) business, provides a suite of PBM offerings including technology solutions, mail delivery services, specialty pharmacy, network, and rebate administration, claims adjudication, and pharmacy discount programs. Elixir also provides prescription discount programs and Medicare Part D insurance offerings for individuals and groups. The company operates over 2,300 retail pharmacy locations across 17 states.
What is the current price of RAD stock?
The current stock price of RAD is 0.6483 USD. The price decreased by -16.81% in the last trading session.
Does RAD stock pay dividends?
RAD does not pay a dividend.
What is the ChartMill technical and fundamental rating of RAD stock?
RAD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
On which exchange is RAD stock listed?
RAD stock is listed on the New York Stock Exchange exchange.
What is the expected growth for RAD stock?
The Revenue of RITE AID CORP (RAD) is expected to decline by -3.31% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.